FDA 483 - Mimi Liu, MD - August 18, 2023

An FDA inspection of Mimi Liu, MD, a clinical investigator in Lakewood, CO, revealed a significant issue with adherence to an investigational plan. The firm failed to ensure safety follow-up calls were performed within the required time frame for multiple subjects across several visit dates, indicating a lapse in patient safety monitoring during a clinical trial.